CLINICAL_TRIALS
research
· 2025-08-17
Clinical Trial Update: A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin [Phase 2]
Summary
A Phase 2 clinical trial evaluating HDM1005 in adults with type 2 diabetes mellitus, currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes | Phase 2 | Status: RECRUITING